ATHE 6-K

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-163

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of March 2025

Alterity Therapeutics Limited

(Name of Registrant)

Level 14, 350 Collins Street, Melbourne, Victoria 3000 Australia

(Address of Principal Executive Office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

This Form 6-K is being incorporated by reference into our Registration Statement on Form S-8 (Files No. 333-251073, 333-248980 and 333-228671) and our Registration Statements on Form F-3 (Files No. 333-274816, 333-251647, 333-231417 and 333-250076)

ALTERITY THERAPEUTICS LIMITED

(a development stage enterprise)

The following exhibits are submitted:

99.1		Application for quotation of securities - ATH

1

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Alterity Therapeutics Limited
By:	/s/ Geoffrey P. Kempler
	Geoffrey P. Kempler
	Chairman

Date: March 14, 2025

2

Exhibit 99.1

	Appendix<br>2A - Application for quotation of securities

Announcement Summary

Entity name

ALTERITY THERAPEUTICS LIMITED

Announcement Type

New announcement

Date of this announcement

Friday March 14, 2025

The +securities to be quoted are:

+Securities issued, transferred or re-classified as a result of options being exercised or other +convertible securities being converted

Total number of +securities to be quoted

	ASX<br>+security code		Security<br>description		Number<br>of<br><br>+securities to be quoted	Issue<br>date
	ATH		ORDINARY<br>FULLY PAID		161	14/03/2025

Refer to next page for full details of the announcement

Appendix 2A - Application for quotation of securities	1 / 6
	Appendix<br>2A - Application for quotation of securities
---	---

Part 1 - Entity and announcement details

1.1 Name of entity

ALTERITY THERAPEUTICS LIMITED

We (the entity named above) apply for +quotation of the following +securities and agree to the matters set out in Appendix 2A of the ASX Listing Rules.

	1.2 Registered number type		Registration number
	ABN		37080699065

1.3 ASX issuer code

ATH

1.4 The announcement is

New announcement

1.5 Date of this announcement

14/3/2025

Appendix 2A - Application for quotation of securities	2 / 6
	Appendix<br>2A - Application for quotation of securities
---	---

Part 2 - Type of Issue

2.1 The +securities to be quoted are:

+Securities issued, transferred or re-classified as a result of options being exercised or other +convertible securities being converted

2.2 The +class of +securities to be quoted is:

Additional +securities in a class that is already quoted on ASX ("existing class")

Appendix 2A - Application for quotation of securities	3 / 6
	Appendix<br>2A - Application for quotation of securities
---	---

Part 3B - number and type of +securities to be quoted (existing class) where issue has not previously been notified to ASX in an

Appendix 3B

Existing +securities converting into additional +securities in an existing class

FROM (Existing Class)

ASX +security code and description

ATHO : OPTION EXPIRING 31-AUG-2026

TO (Existing Class)

ASX +security code and description

ATH : ORDINARY FULLY PAID

	Please state the number of options that were exercised<br>or other +convertible securities that were converted		The first date the options were exercised or other<br>+convertible securities were converted		The last date the options were exercised or other<br>+convertible securities were converted
	161				13/3/2025

Is this all of the options or other +convertible securities on issue of that type (ie have all of those options now been exercised or have all of those convertible securities now been converted)?

No

The right of the holder of the options or other +convertible securities to receive the +underlying securities is being satisfied by:

An issue of new +securities

The underlying +securities being received by the holder are:

Intended to be, but are not yet, quoted by ASX

Were the options being exercised or other +convertible securities being converted issued under an +employee incentive scheme?

No

Issue date

14/3/2025

Will the +securities to be quoted rank equally in all respects from their issue date with the existing issued +securities in that class?

Yes

Appendix 2A - Application for quotation of securities	4 / 6
	Appendix<br>2A - Application for quotation of securities
---	---

Issue details

Number of +securities to be quoted

161

Are the +securities being issued for a cash consideration?

Yes

	In what currency is the cash consideration being<br>paid?		What is the issue price per +security?
	AUD - Australian Dollar		AUD 0.01000000

Any other information the entity wishes to provide about the +securities to be quoted

Appendix 2A - Application for quotation of securities	5 / 6
---	---
	Appendix<br>2A - Application for quotation of securities
---	---

Part 4 - Issued capital following quotation

Following the quotation of the +securities the subject of this application, the issued capital of the entity will comprise:

The figures in parts 4.1 and 4.2 below are automatically generated and may not reflect the entity's current issued capital if other Appendix 2A, Appendix 3G or Appendix 3H forms are currently with ASX for processing.

4.1 Quoted +securities (total number of each +class of +securities quoted on ASX following the +quotation of the +securities subject of this application)

	ASX<br>+security code and description		Total<br>number of<br><br>+securities on issue
	ATH : ORDINARY FULLY PAID		6,656,848,880
	ATHO : OPTION EXPIRING 31-AUG-2026		932,611,269

4.2 Unquoted +securities (total number of each +class of +securities issued but not quoted on ASX)

	ASX<br>+security code and description	Total<br>number of<br><br>+securities on issue
	ATHAAE : OPTION EXPIRING 29-NOV-2026 EX 0.0375	14,250,000
	ATHAAG : OPTION EXPIRING 29-NOV-2026 EX 0.0238	11,900,000
	ATHAAB : OPTION EXPIRING 17-SEP-2025 EX 0.09	35,000,000
	ATHAAK : OPTION EXPIRING 30-DEC-2027 EX 0.01	170,000,000
	ATHAAH : OPTION EXPIRING 19-DEC-2026 EX 0.0105	8,000,000
	ATHAB : OPTION EXPIRING 13-MAR-2029 EX 0.0031	62,500,000
	ATHAA : OPTION EXPIRING 13-MAR-2029 EX 0.004	20,166,667
	ATHAC : OPTION EXPIRING 21-MAR-2029 EX 0.003	120,000,000
	ATHAAD : OPTION EXPIRING 06-JAN-2026 EX 0.032	91,392,720

All values are in US Dollars.

Appendix 2A - Application for quotation of securities	6 / 6